171 related articles for article (PubMed ID: 27121716)
1. Recent Developments in Chimeric NSAIDs as Anticancer Agents: Teaching an Old Dog a New Trick.
Suthar SK; Sharma M
Mini Rev Med Chem; 2016; 16(15):1201-1218. PubMed ID: 27121716
[TBL] [Abstract][Full Text] [Related]
2. NSAIDs: Old Acquaintance in the Pipeline for Cancer Treatment and Prevention─Structural Modulation, Mechanisms of Action, and Bright Future.
Ramos-Inza S; Ruberte AC; Sanmartín C; Sharma AK; Plano D
J Med Chem; 2021 Nov; 64(22):16380-16421. PubMed ID: 34784195
[TBL] [Abstract][Full Text] [Related]
3. Novel dual inhibitors of nuclear factor-kappa B (NF-κB) and cyclooxygenase- 2 (COX-2): synthesis, in vitro anticancer activity and stability studies of lantadene-non steroidal anti-inflammatory drug (NSAID) conjugates.
Suthar SK; Sharma N; Lee HB; Nongalleima K; Sharma M
Curr Top Med Chem; 2014; 14(8):991-1004. PubMed ID: 24660685
[TBL] [Abstract][Full Text] [Related]
4. Influencing COX-2 Activity by COX Related Pathways in Inflammation and Cancer.
Yu T; Lao X; Zheng H
Mini Rev Med Chem; 2016; 16(15):1230-1243. PubMed ID: 27145850
[TBL] [Abstract][Full Text] [Related]
5. Anti-metastatic action of non-steroidal anti-inflammatory drugs.
Hung WC
Kaohsiung J Med Sci; 2008 Aug; 24(8):392-7. PubMed ID: 18926952
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2: a novel target for cancer chemotherapy?
Dempke W; Rie C; Grothey A; Schmoll HJ
J Cancer Res Clin Oncol; 2001 Jul; 127(7):411-7. PubMed ID: 11469677
[TBL] [Abstract][Full Text] [Related]
7. Chemopreventive action of non-steroidal anti-inflammatory drugs on the inflammatory pathways in colon cancer.
Ghanghas P; Jain S; Rana C; Sanyal SN
Biomed Pharmacother; 2016 Mar; 78():239-247. PubMed ID: 26898448
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapeutic properties of phospho-nonsteroidal anti-inflammatory drugs, a new class of anticancer compounds.
Huang L; Mackenzie GG; Sun Y; Ouyang N; Xie G; Vrankova K; Komninou D; Rigas B
Cancer Res; 2011 Dec; 71(24):7617-27. PubMed ID: 22025561
[TBL] [Abstract][Full Text] [Related]
9. Recent developments in chimeric NSAIDs as safer anti-inflammatory agents.
Suthar SK; Sharma M
Med Res Rev; 2015 Mar; 35(2):341-407. PubMed ID: 25319808
[TBL] [Abstract][Full Text] [Related]
10. COX-2 inhibitors in cancer treatment and prevention, a recent development.
Xu XC
Anticancer Drugs; 2002 Feb; 13(2):127-37. PubMed ID: 11901304
[TBL] [Abstract][Full Text] [Related]
11. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation.
Takada Y; Bhardwaj A; Potdar P; Aggarwal BB
Oncogene; 2004 Dec; 23(57):9247-58. PubMed ID: 15489888
[TBL] [Abstract][Full Text] [Related]
12. NF-kappaB, macrophage migration inhibitory factor and cyclooxygenase-inhibitions as likely mechanisms behind the acetaminophen- and NSAID-prevention of the ovarian cancer.
Altinoz MA; Korkmaz R
Neoplasma; 2004; 51(4):239-47. PubMed ID: 15254653
[TBL] [Abstract][Full Text] [Related]
13. ATB-346, a novel hydrogen sulfide-releasing anti-inflammatory drug, induces apoptosis of human melanoma cells and inhibits melanoma development in vivo.
De Cicco P; Panza E; Ercolano G; Armogida C; Sessa G; Pirozzi G; Cirino G; Wallace JL; Ianaro A
Pharmacol Res; 2016 Dec; 114():67-73. PubMed ID: 27777130
[TBL] [Abstract][Full Text] [Related]
14. Is inhibition of cyclooxygenase required for the anti-tumorigenic effects of nonsteroidal, anti-inflammatory drugs (NSAIDs)? In vitro versus in vivo results and the relevance for the prevention and treatment of cancer.
Raz A
Biochem Pharmacol; 2002 Feb; 63(3):343-7. PubMed ID: 11853685
[TBL] [Abstract][Full Text] [Related]
15. The proapoptotic effect of traditional and novel nonsteroidal anti-inflammatory drugs in mammalian and yeast cells.
Farrugia G; Balzan R
Oxid Med Cell Longev; 2013; 2013():504230. PubMed ID: 23983899
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide-donating nonsteroidal anti-inflammatory drugs inhibit the growth of various cultured human cancer cells: evidence of a tissue type-independent effect.
Kashfi K; Rayyan Y; Qiao LL; Williams JL; Chen J; Del Soldato P; Traganos F; Rigas B; Ryann Y
J Pharmacol Exp Ther; 2002 Dec; 303(3):1273-82. PubMed ID: 12438552
[TBL] [Abstract][Full Text] [Related]
17. Anti-Inflammatory Drugs as Anticancer Agents.
Zappavigna S; Cossu AM; Grimaldi A; Bocchetti M; Ferraro GA; Nicoletti GF; Filosa R; Caraglia M
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283655
[TBL] [Abstract][Full Text] [Related]
18. Colorectal cancer and non-steroidal anti-inflammatory drugs.
Ota S; Bamba H; Kato A
Acta Pharmacol Sin; 2000 May; 21(5):391-5. PubMed ID: 11324434
[TBL] [Abstract][Full Text] [Related]
19. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.
Shureiqi I; Chen D; Lotan R; Yang P; Newman RA; Fischer SM; Lippman SM
Cancer Res; 2000 Dec; 60(24):6846-50. PubMed ID: 11156377
[TBL] [Abstract][Full Text] [Related]
20. Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.
Moran EM
J Environ Pathol Toxicol Oncol; 2002; 21(2):193-201. PubMed ID: 12086406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
